Viracta(VIRX) - 2019 Q3 - Earnings Call Transcript

Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2019 Earnings Conference Call November 12, 2019 4:30 AM ET Executives Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer Par Hyare - Senior Vice President Commercial Deepali Suri - Vice President, Clinical Operations Analysts Justin Kim - Oppenheimer Kenneth Atkins - Cowen Operator Good afternoon, ladies and gentlemen, and welcome to the Q3 2019 Sun ...